Clinical trial
TETRAM 2. Treatment With Erythropoetin in Patients With Spinal Trauma With…
NCT00478517 · Hospices Civils de Lyon, Other · Withdrawn
Key facts
| NCT number | NCT00478517 |
|---|---|
| Title | TETRAM 2. Treatment With Erythropoetin in Patients With Spinal Trauma With Neurological Deficit, Maximum Tolerated Dose Study |
| Official title | Treatment With Erythropoetin in Patients With Spinal Trauma With Neurological Deficit, Maximum Tolerated Dose Study. TETRAM2 |
| Acronym | TETRAM2 |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Spinal Trauma With Neurological Deficit |
| Intervention type | Drug |
| Interventions | Erythropoetin (rHuEPO, EPREX®) |
| Enrollment | 20 |
| Start date | May 1, 2007 |
| First posted | May 24, 2007 |
| Last update posted | Mar 11, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: